Cooley, Jingtian & Gongcheng and King & Wood Mallesons advised YZY Biopharma, while Sidley and Merits & Tree acted as legal counsel for the sole sponsor...
Wuhan YZY Biopharma’s HK$176 Million Initial Public Offering
Structure Therapeutics’ $185.3 Million IPO
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
STAR CM’s HK$390 Million IPO
Cooley, Zhong Lun and Maples and Calder, advised STAR CM on the deal. STAR CM, a variety program intellectual property creator and operator, announced its HK$390 million...
GOGOX’s HK$670 Million IPO
CYL & Partners in association with Cooley Hong Kong and Maples represented GOGOX. Paul Hastings advised the joint sponsors and underwriters. GOGOX HOLDINGS LIMITED announced the HK$670...
Huitongda Network Co., Ltd.’s US$284 Million Hong Kong Initial Public Offering and Listing
Clifford Chance has advised Huitongda Network Co., Ltd. on the deal while Cooley advised the joint sponsors and underwriters. Founded in late 2010, Nanjing-based Huitongda is...